Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07623941 · ClinicalTrials.gov registry record
CUIMC Focal Therapy Registry
A clinical trial, sponsored by Columbia University.
- Recruiting
- Registry status
- 1,000
- Enrollment target
NCT07623941 is a clinical trial that is actively recruiting participants, run by Columbia University. The registered enrollment target is 1,000 participants.
The verdict
NCT07623941 is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
Patients undergoing high intensity focused ultrasound (HIFU) or irreversible electroporation (IRE) for prostate cancer will be invited to consent to have their data collected in a detailed comprehensive system to record and store patient, disease, and treatment-related characteristics. No treatment will be given, no randomization will occur, and each patient seen and treated for prostate cancer specifically with HIFU and IRE method in the Department of Urology division of Urologic Oncology within Columbia University Irving Medical Center will be eligible to be enrolled in the database.
Interventions
- PROCEDURE Focal therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2026-01-01 |
| Est. Completion | 2040-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07623941
The ClinicalTrials.gov registry entry for NCT07623941 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Focal therapy is the first listed.
NCT07623941 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07623941 about?
NCT07623941 is a clinical study titled "CUIMC Focal Therapy Registry". Patients undergoing high intensity focused ultrasound (HIFU) or irreversible electroporation (IRE) for prostate cancer will be invited to consent to have their data collected in a detailed comprehensive system to record and store patient, disease, and treatment-related characteristics. No treatment ...
What is the current status of trial NCT07623941?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2026-01-01. Estimated completion is 2040-12-31.
What interventions are being tested in trial NCT07623941?
The interventions under investigation include: Focal therapy (PROCEDURE).
Who is sponsoring clinical trial NCT07623941?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.